Loading company…
VUNO, Inc. develops AI-based medical software, including VUNO Med products for chest X-ray and fundus image analysis.
Founded in 2014 in Seoul, South Korea, VUNO builds AI-driven medical solutions for hospitals, clinics and other healthcare providers, including the VUNO Med range. The company raised KRW 37.8 billion in an IPO on February 26, 2021, and reported revenue of KRW 18,979,814.20 and an EBITDA of KRW -8,012,368.70 in 2024. Yeha Lee is CEO, and the company has completed 7 deals and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in